Your browser doesn't support javascript.
loading
Omalizumab is associated with improved asthma outcomes in children and adolescents with serum immunoglobulin E above dosing guidelines.
Atkinson, Claire E; Schworer, Stephen A; Matthews, Kate; Mills, Katherine; Neighbors, Katherine; Burbank, Allison J; Hernandez, Michelle L.
Afiliación
  • Atkinson CE; Division of Allergy & Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
  • Schworer SA; Division of Allergy & Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
  • Matthews K; Division of Infectious Disease, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
  • Mills K; Children's Research Institute, Department of Pediatrics, University of North Carolina, Chapel Hill, NC.
  • Neighbors K; School of Nursing, University of North Carolina, Chapel Hill, NC.
  • Burbank AJ; Division of Allergy & Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC. Electronic address: allison_burbank@med.unc.edu.
  • Hernandez ML; Division of Allergy & Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
J Allergy Clin Immunol Pract ; 10(10): 2756-2757.e1, 2022 10.
Article en En | MEDLINE | ID: mdl-35803538

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Guideline / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2022 Tipo del documento: Article País de afiliación: Nueva Caledonia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Guideline / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2022 Tipo del documento: Article País de afiliación: Nueva Caledonia